36.4ª.09 Bibliografía Rinitis Alérgica

 
   Capítulo 1. Inroducción.
  • Acero S, Tabar AI, García BE, Echechipias S, Olaguibel JM. Anafilaxia: diagnóstico etiológico. Alergol Immunol Clin 1999;14:133-137.
  • Bauchau V, Durham S. Epidemiological characterization of the intermittent and persistent types of allergic rhinitis. Allergy. 2005;60:350-3.
  • Brostoff J, Scading GK, Male D, Roitt IM, eds. Clinical immunology. Londres: Gower medical ed; 1992. p. 14.9-14.11.
  • Coombs RRA, Gell PGH. Classification of allergic reactions responsible for clinical hypersensitivity and disease. En: Gell PGH, Coombs RRA, Lachmann PJ, editors. Clinical aspects of immunology. 3rd ed. Oxford: Blackwell Scientific Publications, 1975:761-781.
  • Hansel FK. Allergy of the nose and paranasal sinus. St Louis: CV Mosby; 1936.
  • Holgate ST. Allergic disroders. BMJ 2000;320:231-234.
  • Katelaris, CH. Allergic rhinitis and asthma: epidemiological evidence for the link. Clin Exp Allergy Rev. 2003;3:5–8
  • Laguna R, Gómez S, Lavín J, Mateos J, Nuñez M, Chivato T. Reacción alérgica: principios generales. En: Tratado de Farmacoterapia en Alergología. Ed. Luzán 5 SA. Madrid. 2002. Pág. 55-78.
  • Manzo-Rodríguez L, Chávez-Flores S, Rivera-Michelena N, Rodríguez-Orozco AR. Evaluación del Programa de la Especialidad de Medicina Familiar en la Unidad de Medicina Familiar No. 80 del IMSS, de la ciudad de Morelia, Michoacán. Rev Cubana de EducaciónMédica Superior2006;20(3).
  • Manzo-Rodríguez L, Rivera-Michelena N, Rodríguez-Orozco AR. Competencias docentes en profesores de medicina de la Universidad Michoacana de San Nicolás de Hidalgo 2006; 20(2).
  • Mygind N. NasaI Allergy. Ed by Blactwel Scientific Publications, 2 Ed. Oxford, 1982.
  • Navarro A, Colás C, Antón E, Conde J, Dávila I, Dordal MT, Fernández-Parre B, Ibáñez MD, Lluch-Bernal M, Matheu V, Montoro J, Rondón C, Sánchez MC, Valero A; Rhinoconjunctivitis Committee of the SEAIC. Epidemiology of allergic rhinitis in allergy consultations in Spain: Alergológica-2005. J Investig Allergol Clin Immunol. 2009;19 Suppl 2:7-13.
  • Roitt, I.,Brostoff, J.& Male D.: Inmunología. 5a ed. Harcourt, Madrid, 2000.Withington D. Allergy, anaphylaxis and anaesthesia. Canad J Anesth. 1994; 41:12.
  • Schoenwetter WF, Dupclay L Jr, Appajosyula S, Botteman MF, Pashos CL. Economic impact and quality-of-life burden of allergic rhinitis. Curr Med Res Opin 2004,20:305-17. 
  • Settipane RA, Charnock DR. Epidemiology of rhinitis: allergic and nonallergic. Clin Allergy Immunol 2007,19:23-34. 
   Capítulo 02  Fisiopatología de la rinopatía alérgica.
  • Abu Ghazaleh RI, Dunnette SL, Loegering DA, Checkel JL, Kita H, Thomas LL. Eosinophil granule proteins in peripheral blood granulocytes. J Leukocyte Biol 1992; 52: 611-618.
  • Bufe A. Significance of IgE-binding epitopes in allergic disease. J Allergy Clin Inmunol 2001;107:219-221.
  • De Genaro M. Histopatología de la piel durante la realización de pruebas cutáneas in vivo para el estudio de la alergia. Archivos de Alergia e Inmunología Clínica 33:Supl.2: S41- S42, 2002.
  • Hannah J., et al.: The biology of IgE and the basis of allergic disease. Annu. Rev. Immuno121: 579, 2003.
  • Jutel M, Blaser K, Akdis CA. Histamine in chronic allergic responses. J Investig Allergol Clin Immunol. 2005;15:1-8.
  • Lin RY, Schwartz LB, Curry A, Pesola GR, Knight RJ, Lee HS et al. Histamine and tryptase levels in patients with acute allergic reactions: An emergency department-based study. J Allergy Clin Immunol 2000; 106: 65-71
  • Lozano A. Aportes a la fisiopatogenia de la rinitis alérgica: rinitis inducida por ejercicio. Tesis doctoral. Facultad de Medicina. Universidad Católica de Córdoba. Marzo 2002.
  • Monteseirín J, Chacón P, Vega A, Camacho MJ, Bonilla I, Guardia P, et al. ¿Es el neutrófilo una célula reguladora del eosinófilo en los procesos alérgicos mediados por la IgE? Alergol e Inmunol Clin 2004; 1: 7-12.
  • Naclerio RM, Meier HL, Kagey-Sobotka et al. Mediator release after nasal airway challenge with allergen. Am Rev Resp Dis 1983; 129: 597-602.
  • Negro Alvarez JM. Rinitis alérgica. Mecanismos y tratamiento. EDIKA MED 1 Barcelona 1996
  • Rondón C, Fernández J, López S, Campo P, Doña I, Torres MJ, Mayorga C, Blanca M. Nasal inflammatory mediators and specific IgE production after nasal challenge with grass pollen in local allergic rhinitis. J Allergy Clin Immunol. 2009 Nov;124(5):1005-11.
  • Sibbald B. Epidemiology of Allergic Rhinitis. In: Burr ML (ed). Epidemiology in Clinical Allergy. Basel: Karger; 1993;61-79.
  • Straumann A, Simon H-U. The physiological and pathophysiological roles of eosinophils in the gastrointestinal tract. Allergy 2004;59: 15-25.
  • Venge P. Monitoring the allergic inflammation. Allergy 2004; 59: 26-32.
    Capítulo 03 Clinica de la Rinopatia alégica.
  • Dykewicz M. Rhinitis and Sinusitis. J Allergy Clin Inmunol 2003; 111(2):521-522.
  • Kay AB. Allergic diseases and its treatment. N Engl J Med 2001; 344:109-113.
  • Kulig M, Klettke U, Wahn V, et al and the MAS Study Group Berlin. Development of seasonal allergic rhinitis during the first 7 years of life. J Allergy Clin Immunol 2000; 106(5):832-839.
  • Passalacqua G and Baiardini I. Quality of life in allergic rhinitis. Clin Exp Allergy Rev. 2006;6:62-6.
  • Ricketti A. Allergic Rhinitis. En: Roy Patterson: Allergic Diseases: Diagnosis and management. Fifth Edition. Filadelfia: Lippincott-Raven; 1997.
  • Viner AS and Jackman N. Retrospective survey of 1271 patients diagnosed as perennial rhinitis. Clin Allergy 1976; 6: 251-257.

   Capítulo 04 Formas clínicas.

  • Arshad SH, Kurukulaaratchy RJ, Fenn M, Waterhouse L, Matthews S: Rhinitis in 10 years-old children and early life risk factors for its development. Acta Paediatr 2002;91:1334-8.
    Ciprandi G, Mora F, Cassano M, Gallina AM, Mora R. Visual analog scale (VAS) and nasal obstruction in persistent allergic rhinitis. Otolaryngol Head Neck Surg. 2009;141(4):527-9.
  • Dosanjh A. Allergic rhinitis and childhood sleep disordered breathing. Allergol Immunopathol (Madr). 2009;37(3):171-2.
  • Learta D. Contaminación del aire por silos, su incidencia sobre la salud, una población regional. Arch Alerg Inmunol Clin 2001; 32:52-55.
  • Linneberg A, Jorgensen T, Nielsen NH, Mdsen F, Frolund L, Dirksen A. The prevalence of skin-test-positive, allergic rhinitis in Denish adults: two cross-sectional surveys 8 year apart. The Copenhagen Allergy Study Allergy 2000;55(8):767-772.
   Capítulo 05 Pruebas complementarias.
  • Ancona A, Blancos R, Conde-Salazar L. Pruebas epicutáneas o patch test. En: Conde-Salazar L, Ancona A eds. Dermatosis profesionales. Barcelona: Signament edicions; 2000. p. 47-54.
  • Bartolome B., Garcia-Rubio I., Gonzalez G., Martinez-Cocera C. Anafilaxia tras realizacion de pruebas cutaneas en prick. An Med Interna. 2007 Feb 24(2):72-4.
  • Bozzola CM. Pruebas cutáneas de lectura inmediata. Técnica, lectura e interpretación. Arch Alerg Inmunol Clin 2002; 33: suplemento 2.
  • Bieber T., et al.: Fc_RI- expressing antigen-presenting cells: new players in thea topic game. Immunology Today 18 (7 ): 311-313. 1997.
  • Canakcioglu S, Tahamiler R, Saritzali G, Alimoglu Y, Isildak H, Guvenc MG, Acar GO, Inci E. Evaluation of nasal cytology in subjects with chronic rhinitis: a 7-year study. Am J Otolaryngol. 2009;30(5):312-7.
  • Jirapongsanaruruk O, Vichyanond P. Nasal cytology in the diagnosis of allergic rhinitis in children. Ann Allergy Asthma Immunol. 1998;80:165-70.
  • Kniker WT, Hales SW, Lee LK. Diagnostic methods to demonstrate igE antibodies: skin testing techniques. Bull N Y Acad Med. 1981;57(7):524-48.
  • Lane AP, Zweiman B, Lanza DC, Swift D, Doty R, Dhong HJ, Kennedy DW. Acoustic rhinometry in the study of the acute nasal allergic response. Ann Otol Rhinol Laryngol. 1996 Oct;105(10):811-8.  
  • Lewis, T, Grant, RT: Vascular reactions of the skin to injury. Heart 1924 11: 209–265.
  • Romano A, Demoly P.Recent advances in the diagnosis of drug allergy. Curr Opin Allergy Clin Immunol. 2007;7(4):299-303.
  • Scadding GK. Allergic rhinitis: background, symptoms, diagnosis and treatment options. Nurs Times. 2009; 4-17;105(30):24-7.
  • Shearer WT. Specific diagnostic modalities: IgE, skin tests, and RAST. J Allergy Clin Immunol. 1989;84(6 Pt 2):1112-6.
  • Sten B. & K.G. Dreborg.: Skin Testing in Allergen Standardization and Research. Immunol Allergy Clinics North. Amer. 21:329, 2002.
  • Turkeltaub PC. Percutaneus and intracutaneus diagnostic tests os IgE-mediated diseases (inmediate hipersensitivity). En: Kemp SF, Lockey RF, editores. Diagnostic testing of allergic diseases. New York; Marcel Dekker, 2000: 53-87.
 
   Capítulo 06 Diagnóstico.
  • Chaiyasate S, Roongrotwattanasiri K, Fooanant S, Sumitsawan Y. Key nasal symptoms predicting a positive skin test in allergic rhinitis and patient characteristics according to ARIA classification. J Med Assoc Thai. 2009;92(3):377-81. 
  • Chan Y, Kuhn FA. An update on the classifications, diagnosis, and treatment of rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg. 2009;17:204-8.
  • Dykewicz MS, Fineman S, Skoner D, et al. Diagnosis and managemente of rhinitis: Complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol 1998;81:478-518.  
  • Gelardi M, Russo C, Fiorella ML, Fiorella R, Canonica GW, Passalacqua G. When allergic rhinitis is not only allergic. Am J Rhinol Allergy. 2009;23(3):312-5.
  • Kemp AS. Allergic rhinitis. Paediatr Respir Rev. 2009;10(2):63-8.
  • Kaliner M. Rhinosinusitis: The Role of the Allergist in Diagnosis and Treatment. Aci International 1998; 10:141- 148
  • Pant H, Ferguson BJ, Macardle PJ. The role of allergy in rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg. 2009;17:232-8.
     Capítulo 07 Diagnostico diferencial.
  • Di Berardino F. Allergic or nonallergic rhinitis? J Allergy Clin Immunol. 2009 Sep;124(3):620.
  • Doshi J. Rhinitis medicamentosa: what an otolaryngologist needs to know. Eur Arch Otorhinolaryngol. 2009;266(5):623-5.
  • Gane SB, Scadding GK. Diseases mimicking allergic rhinitis. Pediatr Allergy Immunol. 2009 Sep 9.
  • Kalpaklioğlu AF, Kavut AB, Ekici M. Allergic and nonallergic rhinitis: the threat for obstructive sleep apnea. Ann Allergy Asthma Immunol. 2009;103(1):20-5.
  • Rondón C, Doña I, Torres MJ, Campo P, Blanca M. Evolution of patients with nonallergic rhinitis supports conversion to allergic rhinitis. J Allergy Clin Immunol. 2009;123(5):1098-102.
 Capítulo 9.   Tratamiento.
  • Assanasen P, Baroody FM, Naureckas E, Naclerio RM. Warming of feet elevates nasal mucosal surface temperature and reduces the early response to nasal challenge with allergen. J Allergy Clin Immunol. 1999;104:285-93.
  • Blaiss MS. Safety considerations of intranasal corticosteroids for the treatment of allergic rhinitis. Allergy Asthma Proc. 2007;28(2):145-52.
  • Brannan MD, Herron JM, Affrime MB. Safety and tolerability of once-daily mometasone furoate aqueous nasal spray in children. Clin Ther. 1997; 19:1330-9.
  • Bousquet, J. Requirements for medications commonly used in the treatment of allergic rhinitis. Allergy. 2003;58:192–197.
  • Bousquet J, van Cauwenberge P, Ait Khaled N, Bachert C, Baena-Cagnani CE, Cassell HR, Katial RK. Intranasal antihistamines for allergic rhinitis: examining the clinical impact. Allergy Asthma Proc. 2009;30(4):349-57.
  • Cingi C, Kayabasoglu G, Nacar A. Update on the medical treatment of allergic rhinitis. Inflamm Allergy Drug Targets. 2009;8(2):96-103.
  • Bouchard J, Bunnag C, Canonica GW, Carlsen KH, Chen YZ, Cruz AA, Custovic A,Demoly P, Dubakiene R, Durham S, Fokkens W, Howarth P, Kemp J, Kowalski ML, Kvedariene V, Lipworth B, Lockey R, Lund V, Mavale-Manuel S, Meltzer EO, Mullol J, Naclerio R, Nekam K, Ohta K, Papadopoulos N, Passalacqua G, Pawankar R, Popov T, Potter P, Price D, Scadding G, Simons FE, Spicak V, Valovirta E, Wang DY, Yawn B, Yusuf O; GA2LEN. Pharmacologic and anti-IgE treatment of allergicrhinitis ARIA update (in collaboration with GA²LEN). Allergy.2006;61:1086-96.
  • Brannan MD, Herron JM, Affrime MB. Safety and tolerability of once-daily mometasone furoate aqueous nasal spray in children. Clin Ther. 1997; 19:1330-9.
  • Cassell HR, Katial RK. Intranasal antihistamines for allergic rhinitis: examining the clinical impact. Allergy Asthma Proc. 2009 Jul-Aug;30(4):349-57. 
  • Cingi C, Kayabasoglu G, Nacar A. Update on the medical treatment of allergic rhinitis. Inflamm Allergy Drug Targets. 2009 Jun;8(2):96-103.  
  • Ciprandi G, Ricca V, Tosca M, Landi M, Passalacqua G, Canonica GW. Continuous antihistamine treatment controls allergic infl ammation and reduces respiratory morbidity in children with mite allergy. Allergy.1999; 54:358-65.
  • Durham S. Mechanisms of sublingual immunotherapy. J Asthma. 2009;46:322-34.
  • Eng PA, Reinhold M, Gnehm HP. Long-term efficacy of preseasonal grass pollen immunotherapy in children. Allergy 2002; 57:306-312
  • Greenberger PA. Immunotherapy update: mechanisms of action. Allergy Asthma Proc 2002; 23:373-376.
  • Greiff L, Andersson M, Svenson C, et al. Effect of orally inhaled budesonide in seasonal allergic rhinitis. Eur Respir J 1998; 11:1268-1274.
  • Georgalas C, Terreehorst I, Fokkens W. Current management of allergic rhinitis in children. Pediatr Allergy Immunol. 2009 Sep 9. 
  • Helmi AM, El Ghazzawi IF, Mandour MA, Shehata MA.The effect of oestrogen on the nasal respiratory mucosa. An experimental histopathological and histochemical study.J Laryngol Otol. 1975;89(12):1229-41.
  • International Rhinitis Management Working Group. International Consensus report on the diagnosis and management of rhinitis. Allergy 1994; 49 (suppl) 4-34.
  • Keith PK, Scadding GK. Are intranasal corticosteroids all equally consistent in managing ocular symptoms of seasonal allergic rhinitis? Curr Med Res Opin. 2009 Aug;25(8):2021-41. 
  • Losada E. Rinitis intrínseca. In: Tratado de Alergología e Inmunología Clínica. Sociedad Española de Alergología e Inmunología Clínica. Ed. Luzan. Madrid. 1986;II:167-181.
  • Meltzer E, Nolop K, Mesarina-Wicki B. A dose-ranging study mometasone furoate aqueous spray in children with seasonal allergic rhinitis. Allergy. 1997;37(Supp):136. 
  • Mygind N, Johnson NJ, Thomsen J. Intranasal allergen challenge during corticosteroid treatment. Clin Allergy 1977; 7:69.
  • Patterson R, Grammer LC, Greenberger GD. Allergic diseases. Diagnosis and management. eds. Philadelphia:Lippincott-Raven Publishers; 1997.
  • Scadding G, Durham S. Mechanisms of sublingual immunotherapy. J Asthma. 2009 May;46(4):322-34. 
  • Umeki S. Effects of anti-allergic drugs on human neutrophil superoxide-generating NADPH oxidase. Biochem Pharmacol. 1992;43:1511-20.
  • Wilson DR, Torres LI, Durham SR. Sublingual immunotherapy for allergic rhinitis. Cochrane Database Syst Rev 2003; 2:CD002893.